Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
β Scribed by Ian D. Hay
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 196 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Introduction Papillary cancer is the most common neoplasm of the thyroid. The mainstay of treatment is thyroidectomy, but most patients are additionally treated with radioactive iodine (RAI). Its utility is controversial. This study seeks to determine whether RAI use affects patient
In 98 follicular thyroid carcinoma patients with a follow-up of 10-32 years, 1 O-year survival varied in subgroups from 15.5-63.4%. Survival with encapsulated primary tumors was 46.7%, compared to 26.9% in widely invasive tumors, and varied from 59.9-35.8% with growth pattern. In patients younger th
Background and Objectives: The use of lasers, light sources, and radiofrequency devices in Asian patients differs from their use in Caucasians in several respects. Study Design/Materials and Methods: The disease spectrum is very different with pigmentary disorders being more commonly encountered in